This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Zhou, M.-S. Articles by Raij, L. Search for Related Content PubMed Articles by Zhou, M.-S. Articles by Raij, L. Social Bookmarking                         What's this?

Review: Interaction among angiotensin II, nitric oxide and oxidative stress

Nephrology and Hypertension Section, Department of Veterans Affairs Medical Center, and University of Minnesota, Minneapolis, Minnesota, USA

Ahmed Adam

Nephrology and Hypertension Section, Department of Veterans Affairs Medical Center, and University of Minnesota, Minneapolis, Minnesota, USA

Leopoldo Raij

Nephrology and Hypertension Section, Department of Veterans Affairs Medical Center, and University of Minnesota, Minneapolis, Minnesota, USA, raijx001{at}tc.umn.edu

Key Words: angiotensin II • nitric oxide • oxidative stress

References

• BatainehA, Raij L. Angiotensin II, nitric oxide, and end-organ damage in hypertension. Kidney Int Suppl 1998; 68: S14-9.[CrossRef][Medline] [Order article via Infotrieve]
• Grant S., Griendling KK Vascular effects of angiotensin II and AT1 receptor blockade. In: Epstein M and Brunner HR, eds. Angiotensin II Receptor Antagonists. Philadelphia: Hanley & Belfus, Inc. 2000; 235-56.
• Ishani A., Raij L. Hypertension, nitric oxide and end-organ damage. Curr Opin Nephrol Hyperten 1999; 8: 237-41.[CrossRef][Web of Science]
• Warnholtz A., Nickenig G., Schulz E. et al. Increased NADHoxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the reninangiotensin system. Circulation 1999; 99 (15): 2027-33.[Abstract/Free Full Text]
• Griendling KK, Sorescu D., Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86(5): 494-501.[Abstract/Free Full Text]
• Wolin MS Interactions of oxidants with vascular signaling systems. ArteriosclerThromb Vasc Biol 2000; 20 (6): 1430-42.[Abstract/Free Full Text]
• Ronson RS, Nakamura M.,Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res 1999; 44 (1): 47-59.[Abstract/Free Full Text]
• Wolin MS, Burke-Wolin TM, Mohazzab HK Roles for NAD(P)H oxidases and reactive oxygen species in vascular oxygen sensing mechanisms. Respir Physiol 1999;115 (2): 229-38.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000; 87 (3): 179-83.[Abstract/Free Full Text]
• Ohara Y., Peterson TE, Harrison DG Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91 (6): 2546-51.[Web of Science][Medline] [Order article via Infotrieve]
• Vasquez-Vivar J., Kalyanaraman B., Martasek P. et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 1998; 95 (16): 9220-5.[Abstract/Free Full Text]
• Cosentino F., Patton S., d'Uscio LV et al.Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 1998; 101 (7): 1530-7.[Web of Science][Medline] [Order article via Infotrieve]
• Shinozaki K., NishioY, OkamuraT et al. Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats. Circ Res 2000; 87 (7): 566-73.[Abstract/Free Full Text]
• Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 1997; 22 (1-2): 26985.
• Sundaresan M., Yu ZX, Ferrans VJ, Irani K., Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995; 270 (5234): 296-9.[Abstract/Free Full Text]
• De Keulenaer GW, Chappell DC, Ishizaka N., Nerem RM, Alexander RW, Griendling KK Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res 1998; 82 (10): 1094-101.[Abstract/Free Full Text]
• Yeh LH, Park YJ, Hansalia RJ et al. Shear-induced tyrosine phosphorylation in endothelial cells requires Rac1-dependent production of ROS. Am J Physiol 1999; 276 (4 Pt 1):C838-47.[Web of Science][Medline] [Order article via Infotrieve]
• Rubanyi GM, Romero JC, Vanhoutte PM Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986; 250 (6 Pt 2): H1145-9.[Medline] [Order article via Infotrieve]
• Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74 (6): 1141-8.[Abstract/Free Full Text]
• Jaimes EA, Galceran JM, Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 1998; 54 (3): 775-84.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Berry C., Hamilton CA, Brosnan MJ et al. Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 2000; 101 (18): 2206-12.[Abstract/Free Full Text]
• Laursen JB, Rajagopalan S., Galis Z.,Tarpey M., Freeman BA, Harrison DG Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997; 95 (3): 588-93.[Abstract/Free Full Text]
• Heitzer T., Wenzel U., Hink U. et al. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int 1999; 55 (1): 252-60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Rajagopalan S., Kurz S., Munzel T. et al.Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97 (8): 1916-23.[Web of Science][Medline] [Order article via Infotrieve]
• Nakane H., Miller FJ Jr., Faraci FM,Toyoda K., Heistad DD Gene transfer of endothelial nitric oxide synthase reduces angiotensin II-induced endothelial dysfunction. Hypertension 2000; 35 (2): 595-601.[Abstract/Free Full Text]
• Baas AS, Berk BC Differential activation of mitogen-activated protein kinases by H2O2 and O2- in vascular smooth muscle cells. Circ Res 1995; 77 (1): 29-36.[Abstract/Free Full Text]
• Ushio-Fukai M., Alexander RW, Akers M., Griendling KK p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. JBiol Chem 1998; 273 (24): 15022-9.[Abstract/Free Full Text]
• Yanagitani Y., Rakugi H., Okamura A. et al. Angiotensin II type 1 receptor-mediated peroxide production in human macrophages. Hypertension 1999; 33 (1 Pt 2): 335-9.[Abstract/Free Full Text]
• Scheidegger KJ, Butler S., Witztum JL. Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway. J Biol Chem 1997; 272 (34): 21609-15.[Abstract/Free Full Text]
• Oyama J., Shimokawa H., Momii H. et al. Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo. J Clin Invest 1998; 101 (10): 2207-14.[Web of Science][Medline] [Order article via Infotrieve]
• Ferdinandy P., Danial H., Ambrus I., Rothery RA, Schulz R. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 2000; 87 (3): 241-7.[Abstract/Free Full Text]
• Ishiyama S., Hiroe M., Nishikawa T. et al. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation 1997; 95 (2): 489-96.[Abstract/Free Full Text]
• Fukai T., Siegfried MR, Ushio-Fukai M., Cheng Y., Kojda G., Harrison DG Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest 2000; 105 (11):1631-9.[Web of Science][Medline] [Order article via Infotrieve]
• Drummond GR, Cai H., Davis ME, Ramasamy S., Harrison DG Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 2000; 86 (3): 347-54.[Abstract/Free Full Text]
• Landmesser UIF, McCann L., Fukai T., Somers MJ, Harrison DG Uncoupling of endothelial nitric oxide synthase leads to increased vascular suproxide produciton in deoxycorticosterone acetate (DOCA)-salt induced hypertension. Circulation 2000; 102 (18): (Abstract) II-61.
• Dimmeler S., Rippmann V., Weiland U., Haendeler J., Zeiher AM Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res 1997; 81 (6): 970-6.[Abstract/Free Full Text]
• Yang Y., Loscalzo J. Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation 2000; 101 (18): 2144-8.[Abstract/Free Full Text]
• Muller DN, Mervaala EM, Dechend R. et al. Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.Am JPathol 2000; 157 (1):111-22.[Abstract/Free Full Text]
• Ichiki T., Usui M., Kato M. et al. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 1998; 31 (1 Pt 2): 342-8.[Abstract/Free Full Text]
• Usui M., Egashira K., Kitamoto S. et al. Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats. Hypertension 1999; 34 (4 Pt 1): 546-51.[Abstract/Free Full Text]
• Britten MB, Zeiher AM, Schachinger V. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options. J Intern Med 1999; 245 (4): 315-27.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Libby P.,Aikawa M., Kinlay S., Selwyn A., Ganz P. Lipid lowering improves endothelial functions. Int J Cardiol 2000; 74 Suppl 1: S3-S10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Drexler H., Hornig B. Endothelial dysfunction in human disease.JMol Cell Cardiol 1999; 31 (1):51-60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Oskarsson HJ, Heistad DD Oxidative stress produced by angiotensin too. Implications for hypertension and vascular injury. Circulation 1997; 95 (3): 557-9.[Free Full Text]
• Schiffrin EL, Deng LY, Larochelle P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I converting enzyme inhibitor. Comparison with effects of a beta-blocker. Am JHypertens 1995; 8 (3): 229-36.[CrossRef]
• Schiffrin EL, Deng LY Comparison of effects of angiotensin I converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients. Hypertension 1995; 25 (4 Pt 2): 699-703.[Abstract/Free Full Text]
• Mancini GB, Henry GC, Macaya C. et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease.The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996; 94 (3): 258-65.[Abstract/Free Full Text]
• Chobanian AV, Haudenschild CC, Nickerson C., Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 1990; 15 (3): 327-31.[Abstract/Free Full Text]
• Varin R., Mulder P., Tamion F. et al. Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin. Circulation 2000; 102 (3): 351-6.[Abstract/Free Full Text]
• Schiffrin EL, Hayoz D. Role of AT1 angiotensin receptors in vascular remodeling in hypertension. In: Epstein M and Brunner HR, ed. Angiotensin II Receptor Antagonists. Philadelphia: Hanley & Belfus, Inc. 2000: 279-94.
• Nishikawa K. Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage. J Hum Hypertens 1998; 12 (5): 301-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Schiffrin EL, Park JB, Intengan HD, Touyz RM Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000; 101 (14): 1653-9.[Abstract/Free Full Text]
• Nozawa Y., Matsuura N., Miyake H., Yamada S., Kimura R. Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury. Life Sci 1999; 64 (22): 2061-70.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Prasad A., Tupas-Habib T., Schenke WH et al. Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation 2000; 101 (20): 2349-54.[Abstract/Free Full Text]
• Laufs U., La Fata V., Plutzky J., Liao JK Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998; 97 (12): 1129-35.[Abstract/Free Full Text]
• Vogel RA Cholesterol lowering and endothelial function. Am J Med 1999; 107 (5):479-87.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Tsao PS, Cooke JP Endothelial alterations in hypercholesterolemia: more than simply vasodilator dysfunction. J Cardiovasc Pharmacol 1998; 32 (Suppl 3): S48-53.[Web of Science][Medline] [Order article via Infotrieve]
• John S., Schmieder RE Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences.JHypertens 2000; 18 (4): 363-74.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J1996; 10 (7): 709-20.
• Levine GN, Frei B., Koulouris SN, Gerhard MD, Keaney JF Jr.,Vita JA Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 93 (6): 1107-13.[Abstract/Free Full Text]
• Ting HH,Timimi FK, Boles KS, Creager SJ, Ganz P., Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996; 97 (1):22-8.[Web of Science][Medline] [Order article via Infotrieve]
• May JM How does ascorbic acid prevent endothelial dysfunction? Free Radic Biol Med 2000; 28 (9): 1421-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pearce KA, Boosalis MG,Yeager B. Update on vitamin supplements for the prevention of coronary disease and stroke. Am Fam Physician 2000; 62 (6): 1359-66.[Web of Science][Medline] [Order article via Infotrieve]
• Rumiantseva OI, Tutel'ian VA, Pogozheva AV, Askol'zina SE, Lysenkova SL Biologically active food supplements in comprehensive therapy of patients with ischemic heart disease and hypertension and the background of overweight. Vopr Pitan 2000; 69 (1-2): 44-6.[Medline] [Order article via Infotrieve]
• Barbacanne MA, Rami J., Michel JB et al. Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production. Cardiovasc Res 1999; 41 (3): 672-81.[Abstract/Free Full Text]
• Nascimento CA, Kauser K., Rubanyi GM Effect of 17beta-estradiol in hypercholesterolemic rabbits with severe endothelial dysfunction. Am J Physiol 1999; 276 (5 Pt 2): H1788-94.[Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 2, No. 1 suppl, S59-S63 (2001)
DOI: 10.1177/14703203010020011001


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M.-S. Zhou, A. G. Adam, E. A. Jaimes, and L. Raij In Salt-Sensitive Hypertension, Increased Superoxide Production Is Linked to Functional Upregulation of Angiotensin II Hypertension, November 1, 2003; 42(5): 945 - 951. [Abstract] [Full Text] [PDF]

This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Zhou, M.-S. Articles by Raij, L. Search for Related Content PubMed Articles by Zhou, M.-S. Articles by Raij, L. Social Bookmarking                         What's this?